+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Chiral Derivatizing Agent Market - Global Forecast 2026-2032- Product Image
Chiral Derivatizing Agent Market - Global Forecast 2026-2032- Product Image
Sale

Chiral Derivatizing Agent Market - Global Forecast 2026-2032

  • Report

  • 196 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6159779
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Chiral Derivatizing Agents Enable Reliable Enantiomer Differentiation

Chiral derivatizing agents are analytical reagents used to convert enantiomers into diastereomeric derivatives that can be separated and measured by techniques such as chromatography and spectroscopy. Their value is tied to stereochemical purity assessment, impurity characterization, reaction monitoring, and structural confirmation across pharmaceutical, chemical, food, and research applications. Demand is shaped by the need for reproducible methods, defensible analytical documentation, and compatibility with increasingly sensitive instrumentation.

Analytical Workflows Are Shifting Toward Faster, More Selective Methods

The landscape is being transformed by stricter expectations for stereochemical control, greater use of high-resolution analytical platforms, and pressure to shorten development timelines without weakening data quality. Laboratories are refining derivatization protocols to improve reaction completeness, selectivity, stability, and sample throughput. Method robustness, reagent handling, traceability, and ease of integration with liquid chromatography, gas chromatography, and mass spectrometry are becoming central selection criteria.

Artificial Intelligence Strengthens Method Development and Quality Control

Artificial intelligence is contributing to chiral analysis through automated peak recognition, spectral interpretation, anomaly detection, retention-behavior modeling, and experimental-condition optimization. Machine-learning tools can help laboratories prioritize derivatization conditions and identify unusual impurity patterns, while natural-language systems support structured review of analytical records. Human validation remains essential because model outputs depend on representative training data, well-controlled sample preparation, and documented analytical procedures.

Regional Conditions Shape Adoption, Compliance, and Laboratory Capability

North America combines advanced pharmaceutical and analytical infrastructure with strong expectations for method validation and data integrity. Latin America is influenced by expanding pharmaceutical manufacturing, uneven access to specialized instrumentation, and the need for practical, transferable protocols. Europe emphasizes regulatory rigor, sustainability, and sophisticated stereochemical characterization across established research and manufacturing networks. The Middle East is developing analytical capacity alongside pharmaceutical, chemical, and academic investments, while Africa presents varied laboratory maturity and a strong need for accessible quality-control workflows. Asia-Pacific benefits from broad pharmaceutical, chemical, and research activity, with adoption shaped by manufacturing scale, technical training, and local regulatory requirements.

Economic and Institutional Groups Create Distinct Operating Priorities

ASEAN markets are connected by regional supply chains but differ in laboratory infrastructure, regulatory implementation, and technical access. BRICS economies combine substantial pharmaceutical and chemical activity with varied standards, procurement conditions, and domestic analytical capabilities. The European Union supports harmonized regulatory expectations while retaining national differences in implementation and industrial specialization. G7 members generally have mature analytical ecosystems and strong data-governance requirements. GCC countries are investing in scientific and healthcare capabilities, with adoption influenced by localization goals and specialist workforce availability. NATO members span diverse industrial bases, but shared attention to supply resilience, advanced research, and quality assurance can influence laboratory priorities.

Country-Level Adoption Reflects Manufacturing Strength and Technical Readiness

Australia supports research-led analytical applications and geographically distributed laboratory networks. Brazil and Mexico are influenced by pharmaceutical manufacturing, regulatory modernization, and access to specialized services. Canada and the United States have strong research, biopharmaceutical, and quality-control ecosystems. China and India combine large pharmaceutical and chemical sectors with expanding domestic analytical capacity. France, Germany, Italy, Spain, and the United Kingdom maintain mature research and manufacturing environments with demanding validation expectations. Japan and South Korea emphasize precision, process control, and advanced instrumentation. Russia’s adoption is shaped by domestic scientific capacity, industrial priorities, and access to international analytical inputs.

Leaders Should Prioritize Robust Methods, Traceable Supply, and Responsible Automation

Industry leaders should standardize derivatization workflows around reaction selectivity, reproducibility, derivative stability, and instrument compatibility. They should qualify alternative reagent sources, document critical material attributes, and maintain contingency plans for specialized inputs. Investment in analyst training, reference materials, system suitability testing, and interoperable data systems can improve comparability across sites. AI should be introduced through validated use cases with audit trails, performance monitoring, and clear human-approval requirements. Regional operating models should also account for regulatory differences, local service capacity, waste handling, and the availability of skilled analytical personnel.

Research Methodology Combines Market Definition With Evidence-Based Analytical Review

This executive summary defines the market around chiral derivatizing agents used to support stereochemical separation, identification, and quantification. The assessment synthesizes established analytical principles, laboratory workflow requirements, regulatory considerations, technology developments, and geographic operating conditions. Regional, group, and country insights are presented as qualitative interpretations of industrial structure, research capability, compliance expectations, and laboratory readiness. No market estimates, market shares, forecasts, or company-specific claims are included.

Reliable Stereochemical Analysis Will Depend on Method Quality and Operational Discipline

Chiral derivatizing agents remain relevant wherever laboratories must distinguish and quantify enantiomeric forms with defensible evidence. The strongest opportunities for improvement are methodological: better reaction control, stronger validation, reliable supply, digital traceability, and carefully governed automation. Organizations that connect reagent selection with instrument performance, regulatory documentation, workforce capability, and regional operating realities will be best positioned to produce consistent stereochemical data.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Chiral Derivatizing Agent Market, by Type
7.1. Introduction
7.2. Standalone Reagents
7.2.1. Amino Acid And Peptide CDAs
7.2.2. Alcohol And Phenol CDAs
7.2.3. Carboxylic Acid CDAs
7.3. Derivatization Kits
7.3.1. Technique-Specific Workflow Kits
7.3.2. Automation-Ready 96-Well Kits
7.4. Standards And Controls
7.4.1. Isotopically Labeled CDAs
7.4.2. Reference Standards And Controls
7.4.3. Calibrant And System Suitability Sets
8. Chiral Derivatizing Agent Market, by Distribution Channel
8.1. Introduction
8.2. Offline
8.2.1. Direct Sales
8.2.2. Distributors
8.3. Online
8.3.1. Company Websites
8.3.2. Ecommerce Platforms
9. Chiral Derivatizing Agent Market, by Application
9.1. Introduction
9.2. Chromatographic Techniques
9.2.1. GC
9.2.2. HPLC
9.3. Mass Spectrometry
9.3.1. GC-MS
9.3.2. LC-MS
9.4. NMR
9.4.1. 13C NMR
9.4.2. 1H NMR
10. Chiral Derivatizing Agent Market, by End-Use
10.1. Introduction
10.2. Academic Institutions
10.2.1. Research Institutes
10.2.2. Universities
10.3. Biotechnology Firms
10.3.1. Large Biotech
10.3.2. Small Biotech
10.4. Government & Regulatory
10.4.1. EPA
10.4.2. FDA
10.5. Pharmaceuticals
10.5.1. Large Pharma
10.5.2. Small Pharma
11. Chiral Derivatizing Agent Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Chiral Derivatizing Agent Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Chiral Derivatizing Agent Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. abcr GmbH
15.2. BASF SE
15.3. Chiracon GmbH
15.4. Chiral Technologies, Inc.
15.5. Codexis, Inc.
15.6. Daicel Corporation
15.7. Evonik Industries AG
15.8. Johnson Matthey Plc
15.9. Kaival Chemicals Pvt. Ltd.
15.10. Kaneka Corporation
15.11. Lonza Group AG
15.12. Merck KGaA
15.13. Regis Technologies, Inc.
15.14. Solvias AG
15.15. SpiroChem AG
15.16. Thermo Fisher Scientific Inc.
15.17. Tokyo Chemical Industry Co., Ltd.
15.18. W. R. Grace & Co.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Chiral Derivatizing Agent Market, Years Considered for the Study
FIGURE 2. Global Chiral Derivatizing Agent Market, Research Design
FIGURE 3. Global Chiral Derivatizing Agent Market, Research Framework
FIGURE 4. Global Chiral Derivatizing Agent Market, Data Triangulation
FIGURE 5. Global Chiral Derivatizing Agent Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Chiral Derivatizing Agent Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Chiral Derivatizing Agent Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Chiral Derivatizing Agent Market Size, by Distribution Channel, 2025 vs 2032 (%)
FIGURE 9. Global Chiral Derivatizing Agent Market Size, by Distribution Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Chiral Derivatizing Agent Market Size, by Application, 2025 vs 2032 (%)
FIGURE 11. Global Chiral Derivatizing Agent Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Chiral Derivatizing Agent Market Size, by End-Use, 2025 vs 2032 (%)
FIGURE 13. Global Chiral Derivatizing Agent Market Size, by End-Use, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Chiral Derivatizing Agent Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Chiral Derivatizing Agent Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Chiral Derivatizing Agent Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Chiral Derivatizing Agent Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Chiral Derivatizing Agent Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Chiral Derivatizing Agent Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Chiral Derivatizing Agent Market Segmentation & Coverage
TABLE 2. Global Chiral Derivatizing Agent Market Size, 2017-2032 (USD Million)
TABLE 3. Global Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Standalone Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Standalone Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Standalone Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Amino Acid And Peptide CDAs Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Amino Acid And Peptide CDAs Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Amino Acid And Peptide CDAs Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Alcohol And Phenol CDAs Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Alcohol And Phenol CDAs Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Alcohol And Phenol CDAs Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Carboxylic Acid CDAs Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Carboxylic Acid CDAs Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Carboxylic Acid CDAs Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Derivatization Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Derivatization Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Derivatization Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Technique-Specific Workflow Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Technique-Specific Workflow Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Technique-Specific Workflow Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Automation-Ready 96-Well Kits Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Automation-Ready 96-Well Kits Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Automation-Ready 96-Well Kits Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Standards And Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Standards And Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Standards And Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Isotopically Labeled CDAs Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Isotopically Labeled CDAs Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Isotopically Labeled CDAs Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Reference Standards And Controls Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Reference Standards And Controls Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Reference Standards And Controls Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Calibrant And System Suitability Sets Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Calibrant And System Suitability Sets Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Calibrant And System Suitability Sets Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 38. Global Offline Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Offline Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Offline Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Company Websites Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Company Websites Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Company Websites Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Ecommerce Platforms Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Ecommerce Platforms Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Ecommerce Platforms Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 57. Global Chromatographic Techniques Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Chromatographic Techniques Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Chromatographic Techniques Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global GC Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global GC Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global GC Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global HPLC Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global HPLC Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global HPLC Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global GC-MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global GC-MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global GC-MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global LC-MS Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global LC-MS Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global LC-MS Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global NMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global NMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global NMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global 13C NMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global 13C NMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global 13C NMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global 1H NMR Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global 1H NMR Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global 1H NMR Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 85. Global Academic Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Academic Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Academic Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Universities Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Universities Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Universities Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Biotechnology Firms Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Biotechnology Firms Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Biotechnology Firms Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Large Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 98. Global Large Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 99. Global Large Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 100. Global Small Biotech Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Global Small Biotech Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. Global Small Biotech Market Size, by Country, 2017-2032 (USD Million)
TABLE 103. Global Government & Regulatory Market Size, by Region, 2017-2032 (USD Million)
TABLE 104. Global Government & Regulatory Market Size, by Group, 2017-2032 (USD Million)
TABLE 105. Global Government & Regulatory Market Size, by Country, 2017-2032 (USD Million)
TABLE 106. Global EPA Market Size, by Region, 2017-2032 (USD Million)
TABLE 107. Global EPA Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. Global EPA Market Size, by Country, 2017-2032 (USD Million)
TABLE 109. Global FDA Market Size, by Region, 2017-2032 (USD Million)
TABLE 110. Global FDA Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. Global FDA Market Size, by Country, 2017-2032 (USD Million)
TABLE 112. Global Pharmaceuticals Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Global Pharmaceuticals Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. Global Pharmaceuticals Market Size, by Country, 2017-2032 (USD Million)
TABLE 115. Global Large Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 116. Global Large Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 117. Global Large Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 118. Global Small Pharma Market Size, by Region, 2017-2032 (USD Million)
TABLE 119. Global Small Pharma Market Size, by Group, 2017-2032 (USD Million)
TABLE 120. Global Small Pharma Market Size, by Country, 2017-2032 (USD Million)
TABLE 121. Global Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 132. Asia-Pacific Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 133. Asia-Pacific Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 134. Asia-Pacific Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 135. Asia-Pacific Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 136. Asia-Pacific Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 137. Asia-Pacific Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 138. Asia-Pacific Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 139. North America Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 140. North America Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 141. North America Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 142. North America Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 143. North America Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 144. North America Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 145. North America Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 146. North America Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 147. North America Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. North America Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 149. North America Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 150. North America Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 151. North America Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 152. North America Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 153. North America Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 154. North America Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 155. North America Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 156. Latin America Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Latin America Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 158. Latin America Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 159. Latin America Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 160. Latin America Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 161. Latin America Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 162. Latin America Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 163. Latin America Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 164. Latin America Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 165. Latin America Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 166. Latin America Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 167. Latin America Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 168. Latin America Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 169. Latin America Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 170. Latin America Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 171. Latin America Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 172. Latin America Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 173. Europe Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 174. Europe Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 175. Europe Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 176. Europe Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 177. Europe Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 178. Europe Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 179. Europe Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 180. Europe Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 181. Europe Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 182. Europe Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 183. Europe Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 184. Europe Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 185. Europe Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 186. Europe Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 187. Europe Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 188. Europe Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 189. Europe Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 190. Middle East Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 191. Middle East Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 192. Middle East Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 193. Middle East Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 194. Middle East Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 195. Middle East Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 196. Middle East Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 197. Middle East Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 198. Middle East Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Middle East Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 200. Middle East Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 201. Middle East Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 202. Middle East Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 203. Middle East Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 204. Middle East Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 205. Middle East Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 206. Middle East Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 207. Africa Chiral Derivatizing Agent Market Size, by Region, 2017-2032 (USD Million)
TABLE 208. Africa Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 209. Africa Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 210. Africa Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 211. Africa Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 212. Africa Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 213. Africa Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 214. Africa Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 215. Africa Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. Africa Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 217. Africa Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 218. Africa Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 219. Africa Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 220. Africa Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 221. Africa Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 222. Africa Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 223. Africa Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 224. Global Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 225. ASEAN Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 226. ASEAN Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 227. ASEAN Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 228. ASEAN Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 229. ASEAN Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 230. ASEAN Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 231. ASEAN Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 232. ASEAN Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 233. ASEAN Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. ASEAN Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 235. ASEAN Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 236. ASEAN Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 237. ASEAN Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 238. ASEAN Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 239. ASEAN Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 240. ASEAN Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 241. ASEAN Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 242. GCC Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 243. GCC Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 244. GCC Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 245. GCC Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 246. GCC Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 247. GCC Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 248. GCC Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 249. GCC Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 250. GCC Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 251. GCC Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 252. GCC Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 253. GCC Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 254. GCC Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 255. GCC Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 256. GCC Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 257. GCC Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 258. GCC Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 259. European Union Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 260. European Union Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 261. European Union Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 262. European Union Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 263. European Union Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 264. European Union Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 265. European Union Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 266. European Union Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 267. European Union Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. European Union Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 269. European Union Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 270. European Union Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 271. European Union Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 272. European Union Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 273. European Union Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 274. European Union Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 275. European Union Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 276. BRICS Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 277. BRICS Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 278. BRICS Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 279. BRICS Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 280. BRICS Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 281. BRICS Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 282. BRICS Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 283. BRICS Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 284. BRICS Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 285. BRICS Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 286. BRICS Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 287. BRICS Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 288. BRICS Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 289. BRICS Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 290. BRICS Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 291. BRICS Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 292. BRICS Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 293. G7 Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 294. G7 Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 295. G7 Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 296. G7 Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 297. G7 Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 298. G7 Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 299. G7 Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 300. G7 Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 301. G7 Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 302. G7 Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 303. G7 Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 304. G7 Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 305. G7 Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 306. G7 Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 307. G7 Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 308. G7 Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 309. G7 Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 310. NATO Chiral Derivatizing Agent Market Size, by Group, 2017-2032 (USD Million)
TABLE 311. NATO Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 312. NATO Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 313. NATO Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 314. NATO Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 315. NATO Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 316. NATO Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 317. NATO Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 318. NATO Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 319. NATO Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 320. NATO Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 321. NATO Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 322. NATO Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 323. NATO Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 324. NATO Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 325. NATO Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 326. NATO Chiral Derivatizing Agent Market Size, by Pharmaceuticals, 2017-2032 (USD Million)
TABLE 327. Global Chiral Derivatizing Agent Market Size, by Country, 2017-2032 (USD Million)
TABLE 328. United States Chiral Derivatizing Agent Market Size, 2017-2032 (USD Million)
TABLE 329. United States Chiral Derivatizing Agent Market Size, by Type, 2017-2032 (USD Million)
TABLE 330. United States Chiral Derivatizing Agent Market Size, by Standalone Reagents, 2017-2032 (USD Million)
TABLE 331. United States Chiral Derivatizing Agent Market Size, by Derivatization Kits, 2017-2032 (USD Million)
TABLE 332. United States Chiral Derivatizing Agent Market Size, by Standards And Controls, 2017-2032 (USD Million)
TABLE 333. United States Chiral Derivatizing Agent Market Size, by Distribution Channel, 2017-2032 (USD Million)
TABLE 334. United States Chiral Derivatizing Agent Market Size, by Offline, 2017-2032 (USD Million)
TABLE 335. United States Chiral Derivatizing Agent Market Size, by Online, 2017-2032 (USD Million)
TABLE 336. United States Chiral Derivatizing Agent Market Size, by Application, 2017-2032 (USD Million)
TABLE 337. United States Chiral Derivatizing Agent Market Size, by Chromatographic Techniques, 2017-2032 (USD Million)
TABLE 338. United States Chiral Derivatizing Agent Market Size, by Mass Spectrometry, 2017-2032 (USD Million)
TABLE 339. United States Chiral Derivatizing Agent Market Size, by NMR, 2017-2032 (USD Million)
TABLE 340. United States Chiral Derivatizing Agent Market Size, by End-Use, 2017-2032 (USD Million)
TABLE 341. United States Chiral Derivatizing Agent Market Size, by Academic Institutions, 2017-2032 (USD Million)
TABLE 342. United States Chiral Derivatizing Agent Market Size, by Biotechnology Firms, 2017-2032 (USD Million)
TABLE 343. United States Chiral Derivatizing Agent Market Size, by Government & Regulatory, 2017-2032 (USD Million)
TABLE 344. United States Chiral Derivatizing Agent Market Size, by

Companies Mentioned

  • abcr GmbH
  • BASF SE
  • Chiracon GmbH
  • Chiral Technologies, Inc.
  • Codexis, Inc.
  • Daicel Corporation
  • Evonik Industries AG
  • Johnson Matthey Plc
  • Kaival Chemicals Pvt. Ltd.
  • Kaneka Corporation
  • Lonza Group AG
  • Merck KGaA
  • Regis Technologies, Inc.
  • Solvias AG
  • SpiroChem AG
  • Thermo Fisher Scientific Inc.
  • Tokyo Chemical Industry Co., Ltd.
  • W. R. Grace & Co.

Related Topics

Related Reports

Chiral Chemicals Market - Global Forecast 2026-2032 - Product Image

Chiral Chemicals Market - Global Forecast 2026-2032

  • Report
  • 199 Pages
  • Global
From
Diacetone Glucose Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Diacetone Glucose Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Sodium Borohydride Market Insights, Analysis and Forecast 2026-2031 - Product Image

Sodium Borohydride Market Insights, Analysis and Forecast 2026-2031

  • Report
  • 96 Pages
  • Global
From
2026 Pharmaceutical Fine Chemicals Market Outlook: Size, Share, Trends and Forecast 2025-2034 - Product Image

2026 Pharmaceutical Fine Chemicals Market Outlook: Size, Share, Trends and Forecast 2025-2034

  • Report
  • 160 Pages
  • Global
From
Synthetic Camphors - Global Strategic Business Report - Product Image

Synthetic Camphors - Global Strategic Business Report

  • Report
  • 272 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.